High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated

Por Krakstad, Camilla, Birkeland, Even, Seidel, Danila, Kusonmano, Kanthida, Petersen, Kjell, Mjøs, Siv, Hoivik, Erling A., Wik, Elisabeth, Halle, Mari Kyllesø, Øyan, Anne M., Kalland, Karl-Henning, Werner, Henrica Maria Johanna, Trovik, Jone, Salvesen, Helga
Publicado em 2012

PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer

Por Mjos, Siv, Werner, Henrica M. J., Birkeland, Even, Holst, Frederik, Berg, Anna, Halle, Mari K., Tangen, Ingvild L., Kusonmano, Kanthida, Mauland, Karen K., Oyan, Anne M., Kalland, Karl-Henning, Lewis, Aurélia E., Mills, Gordon B., Krakstad, Camilla, Trovik, Jone, Salvesen, Helga B., Hoivik, Erling A.
Publicado no Sci Rep (2017)

Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients

Por Berg, Anna, Hoivik, Erling A., Mjøs, Siv, Holst, Frederik, Werner, Henrica M. J., Tangen, Ingvild L., Taylor-Weiner, Amaro, Gibson, William J., Kusonmano, Kanthida, Wik, Elisabeth, Trovik, Jone, Halle, Mari K., Øyan, Anne M., Kalland, Karl-Henning, Cherniack, Andrew D., Beroukhim, Rameen, Stefansson, Ingunn, Mills, Gordon B., Krakstad, Camilla, Salvesen, Helga B.
Publicado no Oncotarget (2014)